Summary report written by the EBMT Shanghai Office
On November 18, 2022, The Second EBMT - China Scientific Forum was held in Tianjin, a coastal city in China. This forum was co-organized by the EBMT Foundation Shanghai Office and the Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Science & Peking Union Medical College (hereinafter referred to as Tianjin Institute of Haematology), Mr. Zheng Yi, the general representative, and Ms. Yu Jia, the assistant to representatives of EBMT Foundation Shanghai Office have attended this forum offline. About 100 Chinese and European haematologists and young doctors actively participated in this in-person and online event. And there were about 500 persons registered to watch the forum online. Specifically, this forum, themed "Acute Leukaemia", highlights discussions on concerning 4 topics such as Chemotherapy in AML and the latest developments in Emerging Drugs, MRD Guides AML Treatment Choices, Autologous and Allogeneic Haematopoietic Stem Cell Transplantation for AML and more. Participants will have the opportunity to draw on novel research outcomes and updated clinical experience in the fields between China and Europe.
The Executive president of the Forum, Professor Erlie JIANG, Director of the Stem Cell Transplantation Center of Tianjin Institute of Haematology, has presided over the opening ceremony.
At the opening ceremony, the president of Tianjin Institute of Haematology, Professor Tao CHENG welcomed all the experts and colleagues from China and Europe, and he expressed that although many experts were unable to attend the meeting due to the impact of the epidemic, the growing scientific development and the needs of patients still prompted us to carry out scientific exchanges in various fields. Since Tianjin Institute of hematology carried out the first AML autotransplantation in China in 1986, it has been developing new transplantation technologies, hoping to provide good care for our patients with blood diseases through forum exchanges.
The Chinese president of the forum, Professor Jianxiang WANG, the associate president of the Tianjin Institute of Haematology, stressed that Tianjin Institute of Haematology has long-term friendly cooperation with EBMT. Many doctors of Tianjin Institute of Hematology have been trained in EBMT or European Clinical Transplantation Center, which has promoted the development of the BMT in China.
On behalf of Professor Anna Sureda (the president of EBMT), professor Nicolaus Kröger, the European president of the forum, expressed his gratitude for the support of Tianjin Institute of Haematology for the 2nd EBMT-China Scientific Forum. professor Nicolaus Kröger said that he was very glad to see hematologists and young haematological doctors from China and Europe actively participated in the Forum and shared their insights in the field of AML treatment.
And then, the European president of the forum, academician, professor Norbert Claude Gorin (the chief representative of EBMT Foundation Shanghai Office), reviewed the communication and cooperation with Tianjin Institute of Haematology since the 1980s, affirmed the achievements of Tianjin Institute of Haematology in BMT, and hoped that through the exchange of the forum, we could carry out more in-depth cooperation.
Finally, Mrs Zhihong MEI, Deputy Director, Tianjin Municipal Science and Technology Bureau, gave her opening remarks, she expressed that Tianjin Institute of Haematology and EBMT, these two famous international hematological organizations chosed to jointly host the 2nd EBMT-China Scientific Forum in Tianjin, which would promote the development of medical, education and industrial systems in Tianjin. And Tianjin Municipal Science and Technology Bureau would continue to support the international exchanges and cooperation in the field of haematology, and continue to promote the development in the field of haematology and transplantation.
During the 4 thematic sessions of the Forum, haematologists from China, France, Spain, Germany, Italy and the United Kingdom shared and discussed each topic from the perspective of China and the Europe, and each participant felt that they had benefited greatly from the forum.
And during the forum, two senior physicians in charge of the EBMT Trainee Committee also took the opportunity to introduce the rich educational resources and activities provided by EBMT for young doctors around the world.
At the end of the forum, professor Nicolaus Kröger and Professor Erlie JIANG jointly wished the EBMT-China Scientific Forum would be better and better, and wished that we could have face-to-face exchanges in the future. Meanwhile, they expressed their appreciation and gratitude to EBMT Foundation Shanghai Office’s efforts for the exchanges and cooperation in haematology between China and Europe.